Niloufar Farzan

553 total citations
13 papers, 204 citations indexed

About

Niloufar Farzan is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Niloufar Farzan has authored 13 papers receiving a total of 204 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Niloufar Farzan's work include Asthma and respiratory diseases (7 papers), Respiratory and Cough-Related Research (4 papers) and Advanced Chemical Sensor Technologies (3 papers). Niloufar Farzan is often cited by papers focused on Asthma and respiratory diseases (7 papers), Respiratory and Cough-Related Research (4 papers) and Advanced Chemical Sensor Technologies (3 papers). Niloufar Farzan collaborates with scholars based in Netherlands, Iran and United Kingdom. Niloufar Farzan's co-authors include Anke H. Maitland‐van der Zee, Susanne J. H. Vijverberg, Elise M. A. Slob, Peter J. Sterk, Anne H. Neerincx, J. A. M. Raaijmakers, Michael E. Wechsler, Özlem Keskin, Çağatay Karaaslan and Paul Baas and has published in prestigious journals such as CHEST Journal, Clinical & Experimental Allergy and Lung Cancer.

In The Last Decade

Niloufar Farzan

13 papers receiving 203 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Niloufar Farzan Netherlands 9 126 78 36 33 32 13 204
Anirban Sinha Netherlands 9 158 1.3× 112 1.4× 90 2.5× 6 0.2× 76 2.4× 15 279
Ahmed Edris Belgium 7 127 1.0× 87 1.1× 4 0.1× 14 0.4× 31 1.0× 15 194
Rianne de Vries Netherlands 7 98 0.8× 126 1.6× 145 4.0× 8 0.2× 29 0.9× 17 230
César Villarán United States 9 410 3.3× 356 4.6× 9 0.3× 28 0.8× 10 0.3× 11 462
Firoza Begum Bangladesh 6 13 0.1× 14 0.2× 20 0.6× 70 2.1× 21 0.7× 27 225
Kathrin Rupp Germany 5 19 0.2× 49 0.6× 34 0.9× 100 3.0× 71 2.2× 7 289
Ian Beeton United Kingdom 5 75 0.6× 12 0.2× 10 0.3× 8 0.2× 13 0.4× 20 209
Wei Hou China 8 17 0.1× 67 0.9× 33 0.9× 2 0.1× 87 2.7× 25 257
Dillys van Vliet Netherlands 9 187 1.5× 209 2.7× 84 2.3× 5 0.2× 29 0.9× 11 289
Nikolaos Lazarinis Sweden 6 99 0.8× 72 0.9× 11 0.3× 5 0.2× 50 1.6× 8 180

Countries citing papers authored by Niloufar Farzan

Since Specialization
Citations

This map shows the geographic impact of Niloufar Farzan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niloufar Farzan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niloufar Farzan more than expected).

Fields of papers citing papers by Niloufar Farzan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niloufar Farzan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niloufar Farzan. The network helps show where Niloufar Farzan may publish in the future.

Co-authorship network of co-authors of Niloufar Farzan

This figure shows the co-authorship network connecting the top 25 collaborators of Niloufar Farzan. A scholar is included among the top collaborators of Niloufar Farzan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niloufar Farzan. Niloufar Farzan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Vries, R. de, Niloufar Farzan, Frans H. de Jongh, et al.. (2023). Prospective Detection of Early Lung Cancer in Patients With COPD in Regular Care by Electronic Nose Analysis of Exhaled Breath. CHEST Journal. 164(5). 1315–1324. 26 indexed citations
2.
Farzan, Niloufar, et al.. (2021). Evaluation of invasive ventilation rate and comorbidities, clinical signs and lab findings among COVID-19 patients. New Microbes and New Infections. 43. 100925–100925. 2 indexed citations
3.
Muller, Mirte, Rianne de Vries, Peter J. Sterk, et al.. (2021). eNose analysis for early immunotherapy response monitoring in non-small cell lung cancer. Lung Cancer. 160. 36–43. 19 indexed citations
4.
Mahmoodpoor, Ata, Afsaneh Farjami, Niloufar Farzan, et al.. (2021). Taurine in Septic Critically Ill Patients: Plasma versus Blood. Advanced Pharmaceutical Bulletin. 13(1). 143–149. 1 indexed citations
5.
Farzan, Niloufar, et al.. (2020). Mining treatment patterns of glucose-lowering medications for type 2 diabetes in the Netherlands. BMJ Open Diabetes Research & Care. 8(1). e000767–e000767. 9 indexed citations
6.
Keskin, Özlem, Niloufar Farzan, Esra Birben, et al.. (2019). Genetic associations of the response to inhaled corticosteroids in asthma: a systematic review. Clinical and Translational Allergy. 9(1). 2–2. 35 indexed citations
7.
Vijverberg, Susanne J. H., Marjolein Engelkes, Natalia Hernandez‐Pacheco, et al.. (2019). ADRB2 haplotypes and risk of exacerbations in asthmatic children and young adults treated with long-acting ß2-agonists: A meta-analysis in the PiCA consortium. Genes and Environment. PA5388–PA5388. 1 indexed citations
8.
Vries, Rianne de, Erica Dijkers, Paul Brinkman, et al.. (2019). Late Breaking Abstract - Technical validation of breath analysis by eNose in disease diagnosis: Tidal breathing vs. vital capacity manoeuvre. PA3904–PA3904. 1 indexed citations
9.
Vijverberg, Susanne J. H., et al.. (2019). FCER2 T2206C variant associated with FENO levels in asthmatic children using inhaled corticosteroids: The PACMAN study. Clinical & Experimental Allergy. 49(11). 1429–1436. 8 indexed citations
10.
Farzan, Niloufar, Susanne J. H. Vijverberg, Michael Kabesch, Peter J. Sterk, & Anke H. Maitland‐van der Zee. (2018). The use of pharmacogenomics, epigenomics, and transcriptomics to improve childhood asthma management: Where do we stand?. Pediatric Pulmonology. 53(6). 836–845. 20 indexed citations
11.
Slob, Elise M. A., Susanne J. H. Vijverberg, Niloufar Farzan, et al.. (2018). Pharmacogenetics of inhaled long‐acting beta2‐agonists in asthma: A systematic review. Pediatric Allergy and Immunology. 29(7). 705–714. 24 indexed citations
12.
Vijverberg, Susanne J. H., Niloufar Farzan, Elise M. A. Slob, Anne H. Neerincx, & Anke H. Maitland‐van der Zee. (2017). Treatment response heterogeneity in asthma: the role of genetic variation. Expert Review of Respiratory Medicine. 12(1). 55–65. 28 indexed citations
13.
Farzan, Niloufar, et al.. (2016). Pharmacogenomics of inhaled corticosteroids and leukotriene modifiers: a systematic review. Clinical & Experimental Allergy. 47(2). 271–293. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026